ADVANCED SILICON GROUP, INC.
LINCOLN, MA · CIK 0001861637 · Medtech · Private
Rapid portable diagnostic strips and devices for detecting fentanyl and identifying causes of death in drug overdose cases
advancedsilicongroup.com →- Grants
- $2.7M
- 4 awards
- Sector median: 1
- Raised
- $1.0M
- 1 Form D · May 2021
- 65 months since last filing
- Contracts
- $1.4M
- 3 awards · Defense, Health and Human S
- #271 of 4531 in medtech
- Patents
- 19
- 9 granted · 10 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓20152017201920212023
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal grant | National Science Foundation · Phase I · STTR Phase I: Silicon nanowire arrays for the sensitive detection and identification of lung cancer by a blood sample | $225,000 | |
| Federal grant | National Science Foundation · Phase II · SBIR Phase II: Improving silicon nanowire biosensors: throughput, repeatability, and quantifying measurement advantages | $1,355,001 | |
| Federal contract | Department of Defense · Innovative Defense-related Dual-purpose Technologies/solutions | $50,000 | |
| Federal contract· 1 of 2 same day | Department of Defense · Phase II Hypersonics Sibr - Advanced Silicon Group | $950,000 | |
| Federal grant· 2 of 2 same day | Department of Defense · Phase II · Open Call for Innovative Defense-Related Dual-Purpose Technologies/Solutions with a Clear Air Force Stakeholder Need | $700,000 | |
| Private capital raised | Form D · SEC | $1,025,990 | |
| Federal contract | Department of Health and Human Services · Coupled Acoustical Wave Micropillar Detection Of Drugs In Blood Postmortem | $400,000 |
Federal grant · SBIR/STTRFederal contract · USAspendingForm D · SEC
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 268 | Detect | $1.4M | — |
| 269 | Coapt LLC | $1.4M | — |
| 270 | Biotex, Inc. | $1.4M | — |
| 271 | ADVANCED SILICON GROUP, INC. | $1.4M | $1.0M |
| 272 | Olifant Medical, Inc. | $1.4M | — |
| 273 | TISSUE TESTING TECHNOLOGIES LLC | $1.4M | — |
| 274 | AutoGenomics, Inc. | $1.4M | $71M |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Founders & Team
- Marcie BlackDirector · Executive Officer
- Sarah KellyDirector
- William ReverDirector · Executive Officer
- Alan WatsonDirector
Patents
- Auxiliary Electrode To Increase The Signal From Silicon Photoelectric Sensorsapplication
- Nanotextured Silicon Biosensorsapplication
- Nanotextured Silicon Biosensorsgranted
- Metal-assisted Etch Combined With Regularizing Etchapplication
- Process For Fabricating Silicon Nanostructuresgranted
- Metal-assisted Etch Combined With Regularizing Etchgranted
- Screen Printing Electrical Contacts To Nanostructured Areasapplication
- Screen Printing Electrical Contacts To Nanostructured Areasgranted
- Nanostructured Devicesapplication
- Necklaces Of Silicon Nanowiresgranted
- Process For Fabricating Silicon Nanostructuresapplication
- Metal-assisted Etch Combined With Regularizing Etchgranted
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.